Massive Short Interest Surge in BRVE
Braveheart Bio (BRVE) is currently experiencing an unprecedented surge in short selling activity. According to the latest data from Ortex, the short interest as a percentage of free float has skyrocketed to 632%, up from 277% just seven days ago. This 355-point increase in a single week signals extreme bearish conviction and potential volatility ahead. Investors should monitor this ticker closely as the high level of short interest relative to the float creates a significant squeeze risk if the stock price begins to trend upward.
Signal data sourced from Ortex. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.
Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.